The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
Neonc Technologies, Inc.
Radiopharm Theranostics, Ltd
VM Oncology, LLC
DualityBio Inc.
Incyte Corporation
Marengo Therapeutics, Inc.
TransThera Sciences (Nanjing), Inc.
Klus Pharma Inc.
Hutchmed
Cyteir Therapeutics, Inc.
Salubris Biotherapeutics Inc
TransThera Sciences (Nanjing), Inc.
Evopoint Biosciences Inc.
Incyte Corporation
Incyte Corporation
Incyte Corporation
Millennium Pharmaceuticals, Inc.